Miller-Handley H, Harper G, Pham G, Turner L, Shao T, Russi A
J Immunol. 2025; 214(1):192-198.
PMID: 40073258
PMC: 11904129.
DOI: 10.1093/jimmun/vkae007.
Abdullah L, Emiliani F, Vaidya C, Stuart H, Musial S, Kolling F
Immunity. 2025; 58(3):601-615.e9.
PMID: 40020673
PMC: 11903169.
DOI: 10.1016/j.immuni.2025.02.001.
Sinclair L, Youdale T, Spinelli L, Gakovic M, Langlands A, Pathak S
Nat Immunol. 2025; 26(3):429-443.
PMID: 40016525
PMC: 11876071.
DOI: 10.1038/s41590-025-02090-1.
Schienstock D, Hor J, Devi S, Mueller S
Nat Commun. 2025; 16(1):1931.
PMID: 39994207
PMC: 11850795.
DOI: 10.1038/s41467-025-57193-y.
Breart B, Williams K, Krimm S, Wong T, Kayser B, Wang L
Nature. 2025; .
PMID: 39910298
DOI: 10.1038/s41586-024-08510-w.
Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39.
Tan S, Hao J, Ge J, Yang Y, Liu L, Huang J
J Exp Med. 2025; 222(4).
PMID: 39907686
PMC: 11797014.
DOI: 10.1084/jem.20240445.
Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance.
Kremer K, Khammash H, Miranda A, Rutt L, Twardy S, Anton P
Front Immunol. 2025; 15:1497788.
PMID: 39896805
PMC: 11782242.
DOI: 10.3389/fimmu.2024.1497788.
Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients.
Fu L, Zhou E, Li S, Li Z, Wu L, Zhou X
Cancer Immunol Immunother. 2025; 74(3):93.
PMID: 39891760
PMC: 11787060.
DOI: 10.1007/s00262-025-03948-x.
Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening.
Jin W, Deng Y, La Marca J, Lelliott E, Diepstraten S, Konig C
Nat Commun. 2025; 16(1):974.
PMID: 39885149
PMC: 11782673.
DOI: 10.1038/s41467-025-56282-2.
Identification of α-galactosylceramide as an endogenous mammalian antigen for iNKT cells.
Hosono Y, Tomiyasu N, Kasai H, Ishikawa E, Takahashi M, Imamura A
J Exp Med. 2024; 222(2).
PMID: 39704712
PMC: 11660903.
DOI: 10.1084/jem.20240728.
Protocol to study ex vivo T cell priming by conventional dendritic cells from the mouse spleen.
Ashayeripanah M, Villadangos J
STAR Protoc. 2024; 5(4):103382.
PMID: 39666462
PMC: 11697547.
DOI: 10.1016/j.xpro.2024.103382.
Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome.
Vile R, Pulido J, Chen A, Kendall B, Tonne J, Metko M
Res Sq. 2024; .
PMID: 39606441
PMC: 11601838.
DOI: 10.21203/rs.3.rs-5411393/v1.
NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma.
Lindblad K, Donne R, Liebling I, Barcena-Varela M, Lozano A, Ruiz de Galarreta M
Cancer Discov. 2024; 15(3):495-510.
PMID: 39560425
PMC: 11875915.
DOI: 10.1158/2159-8290.CD-24-1215.
MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor-positive HER2-negative breast cancer.
Cai Y, Cai Y, Liu C, Zhang Y, Zhang Y, Liu Y
J Clin Invest. 2024; 135(2.
PMID: 39531335
PMC: 11735090.
DOI: 10.1172/JCI183656.
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.
Vredevoogd D, Apriamashvili G, Levy P, Sinha S, Huinen Z, Visser N
J Immunother Cancer. 2024; 12(11).
PMID: 39510795
PMC: 11552591.
DOI: 10.1136/jitc-2024-010145.
Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants.
Adegoke A, Thangavelu G, Chou T, Petersen M, Kakugawa K, May J
Open Biol. 2024; 14(10):240178.
PMID: 39471840
PMC: 11521602.
DOI: 10.1098/rsob.240178.
CRISPR screens unveil nutrient-dependent lysosomal and mitochondrial nodes impacting intestinal tissue-resident memory CD8 T cell formation.
Raynor J, Collins N, Shi H, Guy C, Saravia J, Lim S
Immunity. 2024; 57(11):2597-2614.e13.
PMID: 39406246
PMC: 11590283.
DOI: 10.1016/j.immuni.2024.09.013.
Tumor-Specific Antigen Delivery for T-cell Therapy via a pH-Sensitive Peptide Conjugate.
Yurkevicz A, Liu Y, Katz S, Glazer P
Mol Cancer Ther. 2024; 24(1):105-117.
PMID: 39382073
PMC: 11695185.
DOI: 10.1158/1535-7163.MCT-23-0809.
Histone lactylation drives CD8 T cell metabolism and function.
Raychaudhuri D, Singh P, Chakraborty B, Hennessey M, Tannir A, Byregowda S
Nat Immunol. 2024; 25(11):2140-2151.
PMID: 39375549
DOI: 10.1038/s41590-024-01985-9.
Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy.
Maliah A, Santana-Magal N, Parikh S, Gordon S, Reshef K, Sade Y
Nat Commun. 2024; 15(1):8354.
PMID: 39333093
PMC: 11437002.
DOI: 10.1038/s41467-024-52079-x.